XFOR FY2029 EPS Boosted by Brookline Capital Markets

Дата публикации: 10-08-2026 05:58:55

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Research analysts at Brookline Capital Markets raised their FY2029 EPS estimates for shares of X4 Pharmaceuticals in a research report issued on Thursday, August 6th. Brookline Capital Markets analyst L. Cann now expects that the company will post earnings per share of $0.99 for the year, up […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Equities Analysts Set Expectations for XENE Q1 Earnings	0	11.84	10-08-2026
2	Q3 EPS Estimate for SAB Biotherapeutics Boosted by Analyst	0	11.83	10-08-2026
3	FY2029 Earnings Estimate for AMLX Issued By HC Wainwright	0	11.9	10-08-2026
4	FY2029 Earnings Forecast for IN8bio Issued By HC Wainwright	0	14.81	10-08-2026
5	FY2027 Earnings Estimate for NVO Issued By Erste Group Bank	0	11.54	10-08-2026
6	Zacks Research Issues Positive Outlook for WaFd Earnings	0	12.28	10-08-2026
7	Energy Fuels FY2026 EPS Estimate Reduced by HC Wainwright	0	13.4	10-08-2026
8	OnKure Therapeutics has cash runway into 2029	0	9.31	05-08-2026
9	Erste Group Bank Comments on OTCMKTS:CFRUY FY2027 Earnings	0	11.9	10-08-2026
10	Erste Group Bank Predicts Increased Earnings for BNP Paribas	0	10.98	10-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 12.66. Источник: www.americanbankingnews.com.